NeuMoDx Molecular and Sentinel Diagnostics are developing multiple new real-time polymerase chain reaction (PCR) assays for use on the NeuMoDx 96 and 288 models of molecular systems through a new collaboration.
New molecular diagnostics will be developed in a range of areas, including for use in post-transplant infections, parasitic and hospital-acquired infections, and respiratory infections. The collaborative work will incorporate Sentinel's Stat-NAT technology, which the companies said was designed to stabilize the activity of the PCR mix to boost shelf life, among other advantages.
